392 related articles for article (PubMed ID: 34207360)
1. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
3. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J; Zhang Z; Ding K
Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
[No Abstract] [Full Text] [Related]
4. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
[TBL] [Abstract][Full Text] [Related]
6. DDR1-targeted therapies: current limitations and future potential.
Wu D; Ding Z; Lu T; Chen Y; Zhang F; Lu S
Drug Discov Today; 2024 May; 29(5):103975. PubMed ID: 38580164
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
Trono P; Ottavi F; Rosano' L
Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
[TBL] [Abstract][Full Text] [Related]
8. Discoidin domain receptors: Micro insights into macro assemblies.
Agarwal G; Smith AW; Jones B
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118496. PubMed ID: 31229648
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship.
Shenoy GP; Pal R; Purwarga Matada GS; Singh E; Raghavendra NM; Dhiwar PS
Bioorg Chem; 2023 Jan; 130():106215. PubMed ID: 36384067
[TBL] [Abstract][Full Text] [Related]
11. Using synthetic peptides and recombinant collagen to understand DDR-collagen interactions.
Chen EA; Lin YS
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118458. PubMed ID: 30880148
[TBL] [Abstract][Full Text] [Related]
12. DDR1 and DDR2 in skin.
Cario M
Cell Adh Migr; 2018; 12(4):386-393. PubMed ID: 29952722
[TBL] [Abstract][Full Text] [Related]
13. Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe.
Röhm S; Berger BT; Schröder M; Chatterjee D; Mathea S; Joerger AC; Pinkas DM; Bufton JC; Tjaden A; Kovooru L; Kudolo M; Pohl C; Bullock AN; Müller S; Laufer S; Knapp S
J Med Chem; 2021 Sep; 64(18):13451-13474. PubMed ID: 34506142
[TBL] [Abstract][Full Text] [Related]
14. Complex roles of discoidin domain receptor tyrosine kinases in cancer.
Mehta V; Chander H; Munshi A
Clin Transl Oncol; 2021 Aug; 23(8):1497-1510. PubMed ID: 33634432
[TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies.
Gao Y; Zhou J; Li J
Cancer Sci; 2021 Mar; 112(3):962-969. PubMed ID: 33377205
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
18. Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I.
Yeung DA; Shanker N; Sohail A; Weiss BA; Wang C; Wellmerling J; Das S; Ganju RK; Miller JLC; Herr AB; Fridman R; Agarwal G
J Mol Biol; 2019 Jan; 431(2):368-390. PubMed ID: 30458172
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
Leitinger B
J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
[TBL] [Abstract][Full Text] [Related]
20. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]